Cerebral evoked potential changes produced by treatment with lithium carbonate

Area of Science:

• Neuroscience
• Psychopharmacology
• Clinical Neurophysiology

Background:

• Previous research suggests lithium carbonate (Li) influences evoked potentials (EPs).
• Understanding Li's central nervous system (CNS) effects is crucial for its clinical application in treating mood disorders.
• Depressive disorders are often associated with altered neurophysiological measures, including EPs.

Purpose of the Study:

• To investigate the effects of lithium carbonate on various sensory evoked potentials (EPs) in patients with depression.
• To correlate EP changes with plasma and erythrocyte lithium levels and depression severity.
• To determine if Li-induced EP alterations are linked to therapeutic effects.

Main Methods:

• 12 patients with depression were studied under placebo and therapeutic lithium carbonate doses.
• Somatosensory (SEP), visual (VEP), and auditory (AEP) evoked potentials were recorded from 14 leads.
• Plasma and erythrocyte Li levels and Hamilton Depression ratings were assessed.

Main Results:

• Lithium significantly altered EP amplitudes across all sensory modalities, primarily increasing positive components and decreasing negative ones.
• Few significant changes in EP latencies or spatial distributions were observed.
• EP amplitude changes correlated with plasma and erythrocyte Li levels, but not with depression ratings.
• Li-induced EP alterations did not consistently normalize pre-existing EP abnormalities in depressed patients.

Conclusions:

• Lithium carbonate induces widespread CNS changes, affecting evoked potentials more than previously reported.
• These neurophysiological effects are related to lithium levels but appear independent of its therapeutic efficacy in depression.
• Further research is needed to elucidate the precise mechanisms underlying Li's impact on neurophysiology and its relationship to mood regulation.